Viewpoint: Coronavirus testing, treatment key to ending national lockdowns

coronavirustesting
Credit: Butch Comegys

First, the bad news: America’s coronavirus epidemic is only beginning, and the suffering will become more searing over the next two weeks. Hospitals in New York City may soon be overwhelmed. New Orleans, Chicago, San Francisco and Seattle may not be far behind.

It will soon be clear why Covid-19 can’t be allowed to rage through the country untamed. …

[Editor’s note: The author was commissioner of the Food and Drug Administration from 2017-19.]

The population tactics are blunt instruments, necessary for isolating hot spots like New York and Seattle. Other places may be able to rely more on individual interventions, which cause less disruption and economic damage.

For this to work, the U.S. will need widespread testing to know where and to what extent the virus is spreading. …

Related article:  Sweden imposes mandatory COVID restrictions, ending its ‘voluntary’ distancing experiment

By the end of next week, the U.S. will have the capacity in place to screen more than 75,000 people a day. South Korea tested 1 in 160 of its people and deployed technology to identify people who were infected and trace contacts. The U.S. should do the same.

Most important is developing a therapy to treat Covid-19 or perhaps prevent people from contracting it. America is home to a vast, dynamic life-science industry. This is its moment. This is why decades of drug investment and development matter so much.

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend